|
Volumn 15, Issue 2, 2005, Pages 277-283
|
Growth inhibition of human pancreatic cancer cells by human interferon-beta gene combined with gemcitabine.
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
BETA INTERFERON;
CATION;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN;
LIPOCORTIN 5;
LIPOSOME;
SOS PROTEIN;
APOPTOSIS;
ARTICLE;
CELL CYCLE;
CELL PROLIFERATION;
CELL SEPARATION;
CULTURE MEDIUM;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FLOW CYTOMETRY;
GENE THERAPY;
GENE TRANSFER;
GENETIC TRANSFECTION;
GENETICS;
HUMAN;
IMMUNOPRECIPITATION;
METABOLISM;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
PANCREAS TUMOR;
PATHOLOGY;
PLASMID;
SIGNAL TRANSDUCTION;
TIME;
TUMOR CELL LINE;
WESTERN BLOTTING;
ANNEXIN A5;
ANTIMETABOLITES, ANTINEOPLASTIC;
APOPTOSIS;
BLOTTING, WESTERN;
CATIONS;
CELL CYCLE;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CELL SEPARATION;
COMBINED MODALITY THERAPY;
CULTURE MEDIA, CONDITIONED;
DEOXYCYTIDINE;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FLOW CYTOMETRY;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
HUMANS;
IMMUNOPRECIPITATION;
INTERFERON-BETA;
LIPOSOMES;
PANCREATIC NEOPLASMS;
PLASMIDS;
RAS GTPASE-ACTIVATING PROTEINS;
SIGNAL TRANSDUCTION;
SOS1 PROTEIN;
TIME FACTORS;
TRANSFECTION;
|
EID: 23044458539
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (13)
|
References (0)
|